Related Experiment Videos
Pulmonary insufficiency produced by isoproterenol
Surgery, Gynecology & Obstetrics
|November 1, 1976
Summary
Isoproterenol infusion in dogs significantly increased pulmonary shunt and cardiac output, indicating beta adrenergic stimulation can worsen pulmonary insufficiency. Caution is advised when using these agents in critically ill patients.
Area of Science:
- Cardiovascular Physiology
- Pulmonary Medicine
- Pharmacology
Background:
- Beta-adrenergic stimulation plays a role in pulmonary insufficiency.
- Understanding the cardiovascular and pulmonary effects of beta-agonists is crucial for clinical practice.
Purpose of the Study:
- To investigate the effects of isoproterenol hydrochloride on pulmonary hemodynamics and shunt in healthy dogs.
- To evaluate the role of beta-adrenergic stimulation in the pathogenesis of pulmonary insufficiency.
Main Methods:
- Twelve healthy, anesthetized, mechanically ventilated dogs were infused with isoproterenol hydrochloride (0.1 microgram/kg/hr) for two hours.
- Hemodynamic parameters including pulmonary shunt, cardiac output, pulmonary artery pressure, pulmonary vascular resistance, and pulmonary artery wedge pressure were monitored.
Main Results:
- Isoproterenol infusion led to a significant increase in pulmonary shunt, cardiac output, and mean pulmonary artery pressure.
- A significant decrease in pulmonary vascular resistance was observed.
- No significant change in pulmonary artery wedge pressure was detected.
Conclusions:
- Beta-adrenergic stimulation, as exemplified by isoproterenol, can induce pulmonary insufficiency.
- The observed shunt is attributed to ventilation-perfusion inequalities from increased pulmonary blood flow and vasodilation.
- Isoproterenol and similar beta-adrenergic agonists warrant cautious use in critically ill patients, especially those at risk for respiratory distress syndrome.